Spotlight Series on Hepatitis C

Be Prepared

Learn the Basics

Choosing which treatment regimen to prescribe a person living with hepatitis C depends on that patient's medical history, HCV genotype, level of liver damage and coinfections. For treatment-naive patients with genotype 1 (the most common genotype) and no liver damage, the AASLD/IDSA guidelines currently recommend:

First-Line Regimens:

For a detailed description of treatment recommendations for more complex patient populations, please refer to the full AASLD/IDSA guidelines, which are updated on a continual basis.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.